Last reviewed · How we verify

NCT03751904

Early Feasibility Study to Assess Safety and Device Performance of AcoustiCare™

Withdrawn NA Last updated 29 January 2019
What this trial tests

NA trial testing AcoustiCare in Heart Failure,Congestive. Withdrawn.

Timeline
25 January 2019
Primary endpoint
28 February 2019
30 March 2019

Quick facts

Lead sponsorSignature Medical, Inc.
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Start date25 January 2019
Primary completion28 February 2019
Estimated completion30 March 2019

Drugs / interventions tested

Conditions studied

Sponsor

Signature Medical, Inc.

Who can join

Adults 18 to 80, any sex, with Heart Failure,Congestive. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

AcoustiCareTM is a non-invasive clinical tool used for the detection of intracardiac pressures using heart sounds in patients with heart failure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Heart Failure,Congestive

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03751904.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing